Navigation Links
Breast milk may provide a personalized screen of breast cancer risk
Date:4/4/2011

ORLANDO, Fla. Breast cancer risk can be assessed by examining the epithelial cells found in breast milk, according to preliminary study results presented at the AACR 102nd Annual Meeting 2011, held April 2-6.

This screening method has the potential to provide a personalized assessment of breast cancer risk, said lead researcher Kathleen F. Arcaro, Ph.D., associate professor of veterinary and animal sciences at the University of Massachusetts Amherst. Given that roughly 80 percent of women give birth, this screen would also cover a large percentage of the female population.

Arcaro and colleagues collected breast milk samples from about 250 women who were scheduled for or who had a breast biopsy. The women submitted fresh samples, which were processed within 24 hours of expression; they provided samples from both breasts.

The researchers recruited about 90 percent of their study population from the Love/Avon Army of Women, which registers women who are willing to participate in breast cancer research. The American Association for Cancer Research is the scientific partner in this effort.

Once researchers received the samples, they isolated the epithelial cells (the potentially cancerous cells) in the breast milk. Then they isolated the DNA to look for epigenetic signals (attachment of methyl groups to DNA), which are the signals that tell the body those genes that should be expressed. These signals were then compared with breast cancer risk assessed using the biopsy results.

Arcaro and colleagues analyzed three genes: RASSF1, GSTP1 and SFRP1. "More than 35 genes have been shown to be methylated in breast cancer," she said.

Of the 104 women with a non-proliferative (low-risk) lesion, results showed no difference in the average epithelial DNA methylation of their biopsied breast vs. non-biopsied breast for RASSF1 and GSTP1. For SFRP1, however, the average methylation was higher in the biopsied breast. Imp
'/>"/>

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , ... June 30, 2015 , ... ... game’s most advanced protection at less thickness than any other padding in football. ... in impact protection and shock absorption, Gameday Armour is engineered with D3O protective ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up ... life. Back pain can range from a dull, constant ache (chronic) to a sudden ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain ...
(Date:6/30/2015)... ... , ... People who want to learn more about the ... experience (NDE) – and also want to understand why the military isn’t recognizing ... invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance at a special ...
(Date:6/30/2015)... ... ... When it comes to volunteering abroad, not many people end up doing ... high. However, there are affordable programs to be had such as those provided by ... such volunteer named Uzma Aishah, a student at the International Medical University in Malaysia, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... AvePoint, ... the general availability of three new apps – AvePoint Watermark, AvePoint ... With the addition of these apps, workers can better streamline everyday business operations and ...
Breaking Medicine News(10 mins):Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4
... from Matigara, Darjeeling District in West Bengal & Kuttanad in ... H7) as per report received from High Animal Security Disease ... reported from these two places. ,In Matigara, ... death of 2500 birds on 5-6th May, 2007. A team ...
... in a support group after diagnosis, use of support ... survivors receive referrals to such programs from their physicians, ... finds that cancer survivors are more likely to attend ... conditions, but there is little active support for such ...
... A leading expert in Germany has spawned a major ... tonnes of methane into the atmosphere every year ... Keppler of the Max Planck Institute for Chemistry has ... January 2006 that they had detected methane exhaled from ...
... women with a history of migraine and other headaches are ... the eye which can lead to severe vision problems ... to a study published in the May 15, 2007, issue ... Neurology. ,For the study, researchers reviewed the headache ...
... conducted to understand dietary patterns and chronic obstructive pulmonary ... halves the chances of developing progressive inflammatory lung disease ... an umbrella term for chronic progressive lung disease, such ... tracked the health of almost 43,000 men, who were ...
... infant mortality, cancer, accidental death, and diabetes than any other ... to a state health official, the Sioux Falls Argus Leader ... Department, at the request of the Zaniya Task Force, recently ... the state's population and found what he called "very somber ...
Cached Medicine News:Health News:Psychosocial Support for Cancer Survivors Needs Strengthening 2Health News:Scientists Saying Against Trees Sparks Debate 2Health News:Mid-Life Headaches May Increase Risk of Vision Problems 2Health News:American Indians in South Dakota Have More Health Problems Than Others in State, Nationwide, Health Official Says 2
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... Officer and Chief Financial Officer, will present at the ... 2015 at 8:00 a.m. ET at Le Parker Meridien ... The presentation will be webcast live and will ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: